Curcumin and proton pump inhibitors for functional dyspepsia: a randomised, double blind controlled trial

Overview of attention for article published in BMJ Evidence-Based Medicine, September 2023

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
One of the highest-scoring outputs from this source (#6 of 1,396)
High Attention Score compared to outputs of the same age (99th percentile)
High Attention Score compared to outputs of the same age and source (99th percentile)

Mentioned by

news: 114 news outlets
blogs: 8 blogs

twitter: 140 tweeters
facebook: 1 Facebook page

Citations

dimensions_citation: 1 Dimensions

Summary News Blogs Twitter Facebook Dimensions citations

So far, Altmetric has seen 147 tweets from 140 users, with an upper bound of 730,264 followers.

@claudiahammond @hcuklive @ProfMattFox @BMJ_EBM @bmj_latest How does this pass peer-review with no placebo? #turmeric #curriculum #omeprazole @doctorkrit https://t.co/R4hbmN0vz1

03:00AM

Reply Retweet Favourite

RT @DavidBroderDO: Turmeric shown to be as effective as PPIs for dyspepsia in randomized, double blind controlled trial. This isn't going…

23 Sep 2023

Reply Retweet Favourite

@theliverdr @FinancialXpress Hey doc, I found this in Medscape https://t.co/XedU9DvpAS https://t.co/eFi3XivN7L

21 Sep 2023

Reply Retweet Favourite

This would be why Curcumin is safer than NSIADS for osteoarthritis of the knee - Curcumin and proton pump inhibitors for functional dyspepsia: a randomised, double blind controlled trial https://t.co/SVhMfNDsS0

21 Sep 2023

Reply Retweet Favourite

This page shows the most recent tweets that mention this research output.

Click here to find out how to access more activity, including 143 additional tweets.